Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $228

Author: Benzinga Newsdesk | April 25, 2024 02:11pm
Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $226 to $228.

Posted In: CME

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist